| CEO Name | Richard Francis |
| Nationality | United Kingdom |
| Net Worth Estimation | $12 million |
Richard Francis, CEO of Teva Pharmaceutical Industries Limited, has an estimated net worth of around $12 million, largely accrued from executive salaries, performance bonuses, and stock awards from previous roles at Sandoz and his compensation package at Teva. His financial profile reflects accumulated earnings and equity holdings typical for industry-leading pharmaceutical executives.
Richard Francis, CEO of Teva Pharmaceutical Industries Limited, has an estimated net worth of $12,000,000, which is 2.5% above the minimum (10,000,000 USD) and 86.7% below the maximum (90,000,000 USD) within the healthcare sector. His net worth positions him towards the lower end of CEO wealth in this business category.
Business Category: Healthcare
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 90000000 USD
Richard Francis Performance in Teva Pharmaceutical Industries Limited
Richard Francis, CEO of Teva Pharmaceutical Industries Limited, demonstrates strategic leadership focused on innovation and operational efficiency. His decisive actions in restructuring and cost management have enhanced the company's financial stability and market position. Under his guidance, Teva has strengthened its R&D pipeline and expanded global reach, driving improved overall performance.
Latest News
Teva Pharmaceutical Industries: CEO Richard Francis Leads Company Turnaround and Growth
Teva, under CEO Richard Francis, has achieved 10 consecutive quarters of growth, driven by innovative products and strategic transformation, with a new focus on R&D efficiency and a 30% operating margin target by 2027. The company's turnaround reflects strong leadership, improved financials, and a renewed commitment to innovation and patient value.
Source: http://www.pharmexec.com/view/the-teva-turnaround-steering-a-company-comeback